Stryker Corp (SYK): Ronda E Stryker , director of Stryker Corp sold 12,000 shares on Apr 12, 2016. The Insider selling transaction was reported by the company on Apr 13, 2016 to the Securities and Exchange Commission. The shares were sold at $109.24 per share for a total value of $1,310,869.75 according the SEC Form 4 Filing.
Company has been under the radar of several Street Analysts.Stryker Corporation is Downgraded by Robert W. Baird to Neutral and the brokerage firm has raised the Price Target to $ 116 from a previous price target of $111 .Earlier the firm had a rating of Outperform on the company shares. The Rating was issued on Apr 13, 2016.Stryker Corporation is Resumed by Barclays to Underweight and the brokerage firm has set the Price Target at $107. The Rating was issued on Apr 11, 2016.Stryker Corporation is Initiated by Nomura to Neutral. The Rating was issued on Mar 17, 2016.Stryker Corporation is Reiterated by Deutsche Bank to Buy and the brokerage firm has raised the Price Target to $ 113 from a previous price target of $107 .The Rating was issued on Feb 1, 2016.
Currently the company Insiders own 7.8% of Stryker Corporation shares according to the proxy statements.In the past twelve weeks, the net percent change held by company insiders has changed by -28.14%.Institutional Investors own 72.08% of Stryker Corporation shares.During last six month period, the net percent change held by insiders has seen a change of -26.84%.
Shares of Stryker Corporation (SYK) ended Monday, Apr 11, 2016 session in red amid volatile trading. The shares closed down -0.29 points or -0.27% at $108.25 with 19,12,587 shares getting traded. Post opening the session at $108.49, the shares hit an intraday low of $108.17 and an intraday high of $108.94 and the price vacillated in this range throughout the day. The company has a market cap of $40,375 M and the number of outstanding shares has been calculated to be 37,29,82,210 shares. The 52-week high of Stryker Corporation is $109.79 and the 52-week low is $86.68.
Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics Medical and Surgical and Neurotechnology and Spine which help improve patient and hospital outcomes.